Condition
Plasma Cell Neoplasms clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Plasma Cell Neoplasms clinical trials that are recruiting, at sites in 2 countries (most in China (1), Italy (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Allogeneic stem cell transplant in relapsed/refractory multiple myeloma
This study looks at real-world use of allogeneic hematopoietic stem cell transplantation in adults with relapsed or refractory multiple myeloma to see how patients fare over time.
-
In Vivo BCMA/GPRC5D Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms
A first-in-human, single-center study tests a two-target CAR-T cell therapy given in vivo to see if it is safe and tolerable in adults with relapsed or refractory plasma cell neoplasms.
Related topics
Quick answers
How many Plasma Cell Neoplasms clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.